Arrowhead Pharmaceuticals
ARWR
#2769
Rank
S$7.83 B
Marketcap
S$55.45
Share price
-2.76%
Change (1 day)
5.99%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2026 (TTM): S-$4.27

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$4.29. In 2025 the company made an earnings per share (EPS) of S-$0.01290 an increase over its 2024 EPS that were of S-$6.45.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.2733030.78%
2025S-$0.01290-99.8%
2024S-$6.45161.39%
2023S-$2.4717.36%
2022S-$2.1019.85%
2021S-$1.7561.9%
2020S-$1.08-216.67%
2019S$0.93-210.77%
2018S-$0.8438.3%
2017S-$0.61-64.93%
2016S-$1.73-16.25%
2015S-$2.0628%
2014S-$1.61-3.85%
2013S-$1.68-31.58%
2012S-$2.45331.82%
2011S-$0.57-51.11%
2010S-$1.16-79.07%
2009S-$5.55-37.68%
2008S-$8.90-16.87%
2007S-$10.7138.33%
2006S-$7.74122.22%
2005S-$3.4842.11%
2004S-$2.45533.33%
2003S-$0.39-99.08%
2002S-$41.8825%
2001S-$33.5033.33%
2000S-$25.13-120%
1999S$125.63-400%
1998S-$41.88-81.48%
1997S-$226.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62-300.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
S-$10.31 139.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$3.34-177.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$25.55-694.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
S-$2.36-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA